Mauna Kea Technologies | Income Statement

Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
9,977.00
11,016.00
8,547.00
8,787.00
6,687.00
6,760
Cost of Goods Sold (COGS) incl. D&A
3,711.00
4,554.00
3,706.00
4,241.00
3,340.00
3,620
Gross Income
6,266.00
6,462.00
4,841.00
4,546.00
3,347.00
3,140
SG&A Expense
18,641.00
21,420.00
19,158.00
15,418.00
14,119.00
16,171
EBIT
12,460.00
-
14,223.00
10,872.00
10,853.00
13,139
Unusual Expense
-
-
232.00
-
-
-
Non Operating Income/Expense
108.00
266.00
81.00
253.00
151.00
306
Interest Expense
100.00
25.00
11.00
-
418.00
484
Pretax Income
12,342.00
15,212.00
13,908.00
10,608.00
11,389.00
13,926
Income Tax
826.00
1,239.00
1,265.00
864.00
1,144.00
1,141
Consolidated Net Income
11,516.00
13,973.00
12,643.00
9,744.00
10,245.00
12,785
Net Income
11,516.00
13,973.00
12,643.00
9,744.00
10,245.00
12,785
Net Income After Extraordinaries
11,516.00
13,973.00
12,643.00
9,744.00
10,245.00
12,785
Net Income Available to Common
11,516.00
13,973.00
12,643.00
9,744.00
10,245.00
12,785
EPS (Basic)
0.84
1.00
0.84
0.55
0.49
0.51
Basic Shares Outstanding
13,727.00
13,905.00
15,031.00
17,587.00
21,123.00
25,201
EPS (Diluted)
0.84
0.90
0.75
0.47
0.49
0.51
Diluted Shares Outstanding
13,727.00
15,588.00
16,814.00
20,607.00
21,123.00
25,201
EBITDA
11,784.00
14,165.00
13,051.00
9,351.00
9,642.00
11,577
Other Operating Expense
85.00
86.00
94.00
-
81.00
108
Non-Operating Interest Income
110.00
123.00
13.00
11.00
33.00
3

About Mauna Kea Technologies

View Profile
Address
9, rue d'Enghien
Paris Ile-de-France 75010
France
Employees -
Website http://www.maunakeatech.com
Updated 07/08/2019
Mauna Kea Technologies SA is a global medical device company focused on eliminating uncertainties related to the diagnosis and treatment of cancer and other diseases. The company engages in the design, development, and sale of optical biopsy devices and tools to visualize and detect abnormalities in the gastro-intestinal and pulmonary tracts primarily in cancer patients. Its product, Cellvizio, a probe-based Confocal Laser Endomicroscopy system, provides physicians and researchers high resolution cellular views of tissue inside the body.